The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein.
about
Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.Degrees of maturity: the complex structure and biology of flavivirusesJapanese encephalitis: the virus and vaccinesDengue viruses - an overviewSystematic Bioinformatic Approach for Prediction of Linear B-Cell Epitopes on Dengue E and prM ProteinPrM- and cell-binding domains of the dengue virus E protein.Acid-resistant bovine pestivirus requires activation for pH-triggered fusion during entry.Mutagenesis of the signal sequence of yellow fever virus prM protein: enhancement of signalase cleavage In vitro is lethal for virus production.A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in miceMapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein EFunctional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein.Assembly and Maturation of the Flavivirus Kunjin Virus Appear To Occur in the Rough Endoplasmic Reticulum and along the Secretory Pathway, RespectivelyResuscitating mutations in a furin cleavage-deficient mutant of the flavivirus tick-borne encephalitis virusFolding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulumStructures of immature flavivirus particlesRecent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and PathogenesisAntibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope ProteinOligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pHFormation of the flavivirus envelope: role of the viral NS2B-NS3 proteaseSynthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate formRecombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functionsProteolytic activation of tick-borne encephalitis virus by furinMaturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated NeutralizationChimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in miceA Single N-Linked Glycosylation Site in the Japanese Encephalitis Virus prM Protein Is Critical for Cell Type-Specific prM Protein Biogenesis, Virus Particle Release, and Pathogenicity in MiceClosing the door on flaviviruses: Entry as a target for antiviral drug designStructural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine DevelopmentProgress on the development of therapeutics against West Nile virusComplement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile VirusImmature Dengue Virus: A Veiled Pathogen?Focus on flaviviruses: current and future drug targetsThe flavivirus precursor membrane-envelope protein complex: structure and maturationDeconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and ImmunityAdvances in Zika Virus Research: Stem Cell Models, Challenges, and OpportunitiesCharacterization of cytopathic factors through genome-wide analysis of the Zika viral proteins in fission yeastThe complexity of antibody-dependent enhancement of dengue virus infectionA single amino acid substitution in the core protein of West Nile virus increases resistance to acidotropic compoundsA single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesisConformational changes of the flavivirus E glycoproteinUnstructural biology of the Dengue virus proteins.
P2860
Q22010245-1A88F18A-6407-4E03-9348-2AC88F40569DQ26824712-58A6404E-E394-4E3C-A46D-718BFCAD3769Q27010434-666A28C4-CFDD-4396-AD5C-F0FF666A63A3Q27026302-D974734A-ADB2-40AD-8759-E014E5050DA5Q27468788-FD4D1B91-CF32-42D8-948F-E1B086CF33FAQ27469382-FC2A664F-7D43-4ACD-9B63-2BAC1709B915Q27469429-89ED6D85-DAB7-4804-A22F-3A3901E483B2Q27469616-15C3EAAA-62A3-40D1-A364-D0299ABDB8CFQ27469658-31B81F2E-CA4D-4284-AF39-743D939AE605Q27469713-3154CFCA-38CE-4BA4-9811-AB31C9021C84Q27469721-80112AB9-436A-4886-B07C-FDCE769DFE37Q27469877-2160E321-D2E5-40AF-B3AA-EB5F02EB0200Q27471536-EECEB88C-F0C9-42C5-8EA0-BBB004BE2918Q27472959-F0A89685-C5BC-43BD-BBFE-F66092943B8EQ27477478-9743DF43-7E7C-4ED2-953E-2D91CCEC5653Q27477646-4FEF9661-685F-4C1C-9825-C06505461B23Q27477718-A51C0A17-5742-4D38-BC63-3D3A75917F75Q27478446-A4B5758A-B82B-4064-A9BA-7A67FA229866Q27478465-E33FA0A8-5639-4993-8078-5AF3A0CE9FC1Q27480299-206861C6-BE24-4F6B-8420-539129F48A3DQ27480395-F0B014FD-7486-4225-B20A-AE22660356B8Q27480892-AD0D64D6-4530-414D-BD8F-8D9B93AB1060Q27485890-1B349685-27B6-4A5E-9A82-0C7758379731Q27486063-1E328A4C-EFD4-4E76-B2ED-8D76133D65CCQ27486779-EF892220-FD8A-40DF-B195-1B9A60E7726DQ27487953-1DE00D6E-EC0E-4CFE-809C-F28F0EF3F84EQ27488364-54D45EED-83D9-4367-A59F-DEDCD5FF4FE7Q27489893-1EA005F4-0719-427B-AD02-6E4FAF9ACD95Q27490423-2E4470AC-46D8-4BE4-B8D6-9F4309F77288Q27490592-52066592-A83E-4E5F-B367-BFE7CDC075E2Q27490926-BC3B9BF7-D0C0-4028-AFD3-847DCCB64586Q27650164-A524A7AC-10CF-4442-A6BF-77DF78EF8FB5Q27654848-074B2739-6B09-4946-90AA-2281538E9404Q27980653-7768C351-9022-4C5D-9EF3-BCC9008C7DADQ28114506-5C8592F7-D018-4CCB-A490-92D6C8D2B4D9Q28250383-C4CAE4F3-6573-42E5-9D78-A34EA2B6878AQ28534723-E827D850-8977-4A97-A159-96BC67A71181Q28804076-682414AC-CCE7-4F0D-B11D-13BD4FB35FBEQ29618170-40E23A8D-98A5-49B8-B0FE-3C7093EEF9B3Q30375946-D62F0D59-EFB9-4792-8FE1-FEF336B02B05
P2860
The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
The Murray Valley encephalitis ...... e R2 domain of E glycoprotein.
@en
The Murray Valley encephalitis ...... e R2 domain of E glycoprotein.
@nl
type
label
The Murray Valley encephalitis ...... e R2 domain of E glycoprotein.
@en
The Murray Valley encephalitis ...... e R2 domain of E glycoprotein.
@nl
prefLabel
The Murray Valley encephalitis ...... e R2 domain of E glycoprotein.
@en
The Murray Valley encephalitis ...... e R2 domain of E glycoprotein.
@nl
P2093
P1433
P1476
The Murray Valley encephalitis ...... e R2 domain of E glycoprotein.
@en
P2093
P304
P356
10.1016/0042-6822(92)90267-S
P407
P577
1992-12-01T00:00:00Z